BOCA RATON, Fla. - Entero Therapeutics, Inc. (NASDAQ:ENTO), a clinical-stage biopharmaceutical company with a market capitalization of $2.45 million, today announced the appointment of Richard Paolone ...

Richard Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law, and mergers and acquisitions. Mr. Paolone plays a key role in advising on a range ...

Constipation Treatment Market Constipation Treatment Market Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Constipation Treatment - Global Strategic Business Report" has been added to ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

This announcement is based on a press release statement from Silo Pharma. With a current ratio of 7.9, the company maintains strong liquidity to fund its development pipeline, though analysts tracked ...

SPC-15 is an intranasal serotonin 5-HT4 receptor agonist aimed at treating stress-induced psychiatric disorders such as PTSD and anxiety. With its potential eligibility for the FDA’s streamlined ...

Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric conditions alongside increased risks of gastrointestinal and musculoskeletal issues Study ...